Overview

BCG vaccine


'BCG vaccine' can also refer to...

BCG vaccine

Faith, Failure, and the BCG Vaccine

Neonatal BCG Vaccine and Response to the Tuberculin Test in BCG Vaccinated Children in Contact with Tuberculosis Patients in Recife, Brazil

Recombinant BCG approach for development of vaccines: cloning and expression of immunodominant antigens of M. tuberculosis

BCG vaccine effectiveness in preventing tuberculosis and its interaction with human immunodeficiency virus infection

Protection by BCG Vaccine Against Tuberculosis: A Systematic Review of Randomized Controlled Trials

Evaluation of a Human BCG Challenge Model to Assess Antimycobacterial Immunity Induced by BCG and a Candidate Tuberculosis Vaccine, MVA85A, Alone and in Combination

Protection against murine tuberculosis by an attenuated recombinant Salmonella typhimurium vaccine strain that secretes the 30-kDa antigen of Mycobacterium bovis BCG

The Effect of Zinc Supplementation During Pregnancy on Immune Response to Hib and BCG Vaccines in Bangladesh

A case-control study of the effectiveness of BCG vaccine for preventing leprosy in Yangon, Myanmar.

Is all-cause mortality a useful epidemiological endpoint in vaccine trials? An example of BCG (Bacille-Calmette-Guerine)

Pulmonary but Not Subcutaneous Delivery of BCG Vaccine Confers Protection to Tuberculosis-Susceptible Mice by an Interleukin 17–Dependent Mechanism

Comparative structural study of the mannosylated-lipoarabinomannans from Mycobacterium bovis BCG vaccine strains: characterization and localization of succinates

The Recombinant BCG ΔureC::hly Vaccine Targets the AIM2 Inflammasome to Induce Autophagy and Inflammation

Dose-Finding Study of the Novel Tuberculosis Vaccine, MVA85A, in Healthy BCG-Vaccinated Infants

OX40 Ligand Fusion Protein Delivered Simultaneously With the BCG Vaccine Provides Superior Protection Against Murine Mycobacterium tuberculosis Infection

 

More Like This

Show all results sharing this subject:

  • Public Health and Epidemiology

GO

Show Summary Details

Quick Reference

The vaccine against tuberculosis prepared from live attenuated bovine tubercle bacilli using a method developed by the French microbiologists Léon Calmette (1863–1933) and Camile Guérin (1872–1961) in the late 1920s. Initial trials had catastrophic results because of contamination with virulent strains of tubercle bacilli and other organisms, but further trials demonstrated the safety and efficacy of BCG vaccine, and it has been widely used since the 1940s, now especially as part of vaccination regimens in low- and middle-income countries.

Subjects: Public Health and Epidemiology.


Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.